Using Art Participation to Promote Psychosocial Health Among People With Physical Disabilities: A… (NCT07350603) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Using Art Participation to Promote Psychosocial Health Among People With Physical Disabilities: A Feasibility Study
50 participantsStarted 2026-06-01
Plain-language summary
This study aims to explore the feasibility of a newly developed theory-based inclusive art participation program for promoting psychosocial health of people with physical disabilities living in residential care homes.
Specifically, the feasibility is assessed following the framework proposed by Bowen et al. (2009), which encompassed five aspects, including demand, implementation, practicality, preliminary effects, and acceptability. As for the preliminary effects, this project will evaluate self-esteem, sense of control, self-efficacy, mood, and social connectedness after the completion of program.
This study will adopt a one group pretest-posttest approach with quasi-experimental design to collect both quantitative and qualitative data, employing a mixed-methods study design.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* aged 18 years old or above
* have single or multiple physical disabilities caused by disease, accident, or aging, characterized by long-term impairments in mobility, stamina, or dexterity
* reside in residential care home
* only have a mild cognitive impairment defined as having a Montreal Cognitive Assessment (MoCA) score which fall above the 16th percentile
* have upper limb function with below a score of 50 assessed by Quick Disability of the Arm, Shoulder and Hand (DASH) Questionnaire
* able to remain in sitting position independently
* able to understand and communicate with Chinese, and (8) able to read Traditional Chinese.
Exclusion Criteria:
* individuals with severely impaired speaking, hearing, or visual acuity
* individuals have physical unwell for participating in this study
* individuals are currently taking part in other research projects or receiving other programs for promoting psychosocial health
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Preliminary effects - Sense of control
Timeframe: From enrollment to the end of treatment at 6 weeks.
2
Preliminary effects - Self-esteem
Timeframe: From enrollment to the end of treatment at 6 weeks.
3
Preliminary effects - Self-efficacy
Timeframe: From enrollment to the end of treatment at 6 weeks.
4
Preliminary effects - Mood
Timeframe: From enrollment to the end of treatment at 6 weeks.
5
Preliminary effects - Social connectedness
Timeframe: From enrollment to the end of treatment at 6 weeks.